Renalytix PLC
LSE:RENX
Renalytix PLC
LSE:RENX
Price:
1.95
GBX
Market Closed
Market Cap:
£8.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Renalytix PLC
LSE:RENX
|
UK |
Multiples-Based Value
The
Multiples-Based Value for
Renalytix PLC (RENX)
under the Base Case is
0.69
GBX.
Compared with the current market price of 1.95 GBX, the stock appears
Overvalued by 65%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RENX
Multiples-Based Value
Base Case
0.69
GBX
Overvaluation 65%
Multiples Across Competitors
RENX Competitors Multiples
Renalytix PLC Competitors
Renalytix PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Renalytix PLC
LSE:RENX
|
8.5m GBP | 3.4 | -0.6 | -0.9 | -0.9 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | 21.9 | 43.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
24.8B USD | 7.8 | 27.3 | 18.5 | 19.3 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.3B AUD | 54.1 | 57.3 | 70.9 | 70.9 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.2 | 21.9 | 10.7 | 13 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.5B SEK | 19.4 | 84.7 | -116.9 | -116.9 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.1B USD | 3.7 | 35.9 | 13.4 | 20.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
3.9B USD | 6.1 | 16.3 | 12.6 | 13.2 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | 267.9 | 4 290.1 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
253.5B INR | 8.5 | 39.4 | 26 | 29.2 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 8.7 | -60.8 | -119.4 | -119.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
